These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2732590)

  • 1. [Antiarrhythmic drug therapy for arrhythmogenic right ventricular dysplasia].
    You S; Miyazaki T; Noya K; Ogawa S; Nakamura Y
    Nihon Naika Gakkai Zasshi; 1989 Mar; 78(3):387-92. PubMed ID: 2732590
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term management of arrhythmogenic right ventricular dysplasia.
    Sevick RJ; Wyse DG
    Can Med Assoc J; 1983 Feb; 128(4):418-20. PubMed ID: 6217885
    [No Abstract]   [Full Text] [Related]  

  • 3. [Paroxysmal atrial arrhythmias in arrhythmogenic cardiomyopathy of the right ventricle with a familial character: the role of right atrial involvement].
    Proclemer A; Cuzzato AL; Morocutti G; Rocco M; Feruglio GA
    G Ital Cardiol; 1992 Nov; 22(11):1315-26. PubMed ID: 1297618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular dysplasia: case report presentation and review of the literature.
    Kouvaras G; Chronopoulos G; Solomos D; Sofronas G; Nikolaou P; Kozyrakis M; Cokkinos DV
    Acta Cardiol; 1988; 43(5):615-23. PubMed ID: 2467467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.
    Rothman MT
    Br Med J; 1980 Mar; 280(6218):922-3. PubMed ID: 7388371
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy?
    Manyari DE; Klein GJ; Gulamhusein S; Boughner D; Guiraudon GM; Wyse G; Mitchell LB; Kostuk WJ
    Circulation; 1983 Aug; 68(2):251-7. PubMed ID: 6861304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
    Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
    Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex frequency-dependent interaction of class-I antiarrhythmic drugs as they affect intraventricular conduction.
    Lee JK; Takanaka C; Nonokawa M; Kato H; Yabe S; Kodama I; Toyama J
    Eur Heart J; 1995 Jun; 16(6):832-41. PubMed ID: 7588928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gated blood pool imaging in the diagnosis and management of arrhythmia].
    Yamamoto S; Kawai N; Okada M; Matsushima H; Kato R; Sotobata I; Tanahashi Y
    J Cardiogr; 1985 Jun; 15(2):513-23. PubMed ID: 2419456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of epsilon wave in lead aVR in an 83-year old male patient with arrhythmogenic cardiomyopathy.
    Peters S
    Int J Cardiol; 2015 Nov; 199():401-2. PubMed ID: 26247797
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute oral antiarrhythmic testing with disopyramide.
    García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
    Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug therapy (Part 1). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Sep; 88(3):452-60. PubMed ID: 2863091
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
    Naccarella F; Del Corso P; Palmieri M; Cantelli I; Lentini G; Bracchetti D
    G Ital Cardiol; 1981; 11(3):338-44. PubMed ID: 6169577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous antiarrhythmic drugs: newer aspects of therapy.
    Abbott JA
    Angiology; 1982 Apr; 33(4):251-8. PubMed ID: 7041701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.